Found 3 results
Filters: Author is S.T. Zhao  [Clear All Filters]
Y. W. Sun, Xuan, Q., Shu, Q. A., Wu, S. S., Chen, H., Xiao, J., Xiang, P., Zhu, Y. P., Wang, F. L., and Zhao, S. T., Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma, vol. 12, pp. 1045-1053, 2013.
Athanassiadou P, Grapsa D, Athanassiades P, Gonidi M, et al. (2008). The prognostic significance of COX-2 and survivin expression in ovarian cancer. Pathol. Res. Pract. 204: 241-249. PMid:18171606   Celen O, Kahraman I, Yildirim E and Berberoglu U (2004). Correlation of vascular endothelial growth factor (VEGF) and CEA with clinicopathological variables in colorectal cancer patients. Neoplasma 51: 293-299. PMid:15254661   Deveraux QL and Reed JC (1999). IAP family proteins - suppressors of apoptosis. Genes Dev. 13: 239-252. PMid:9990849   Fleshner NE, Herr HW, Stewart AK, Murphy GP, et al. (1996). The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 78: 1505-1513.<1505::AID-CNCR19>3.0.CO;2-3   Grabowski P, Kuhnel T, Muhr-Wilkenshoff F, Heine B, et al. (2003). Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br. J. Cancer 88: 115-119. PMid:12556969 PMCid:2376783   Ikeguchi M, Ueda T, Sakatani T, Hirooka Y, et al. (2002). Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. Diagn. Mol. Pathol. 11: 33-40. PMid:11854600   Islam A, Kageyama H, Takada N, Kawamoto T, et al. (2000). High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19: 617-623. PMid:10698506   Jin Q, Hemminki K, Enquist K, Lenner P, et al. (2005). Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin. Cancer Res. 11: 3647-3653. PMid:15897560   Kirkali Z, Chan T, Manoharan M, Algaba F, et al. (2005). Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66: 4-34. PMid:16399414   Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, et al. (2004). VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 46: 293-298. PMid:15541813   Monzo M, Rosell R, Felip E, Astudillo J, et al. (1999). A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J. Clin. Oncol. 17: 2100-2104. PMid:10561264   Mori A, Wada H, Nishimura Y, Okamoto T, et al. (2002). Expression of the antiapoptosis gene survivin in human leukemia. Int. J. Hematol. 75: 161-165. PMid:11939262   Plate KH, Breier G, Weich HA and Risau W (1992). Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848. PMid:1279432   Riedel F, Gotte K, Bergler W and Hormann K (2001). Inverse correlation of apoptotic and angiogenic markers in squamous cell carcinoma of the head and neck. Oncol. Rep. 8: 471-476. PMid:11295065   Rohayem J, Diestelkoetter P, Weigle B, Oehmichen A, et al. (2000). Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients. Cancer Res. 60: 1815-1817. PMid:10766164   Sato K, Sasaki R, Ogura Y, Shimoda N, et al. (1998). Expression of vascular endothelial growth factor gene and its receptor (flt-1) gene in urinary bladder cancer. Tohoku J. Exp. Med. 185: 173-184. PMid:9823778   Schultz IJ, Kiemeney LA, Witjes JA, Schalken JA, et al. (2003). Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. Anticancer Res. 23: 3327-3331. PMid:12926071   Schultz IJ, Kiemeney LA, Karthaus HF, Witjes JA, et al. (2004). Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas. Clin. Chem. 50: 1425-1428. PMid:15277352   Smith BD, Smith GL, Carter D, Sasaki CT, et al. (2000). Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J. Clin. Oncol. 18: 2046-2052. PMid:10811669   Suzuki A, Ito T, Kawano H, Hayashida M, et al. (2000). Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 19: 1346-1353. PMid:10713676   Swana HS, Grossman D, Anthony JN, Weiss RM, et al. (1999). Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N. Engl. J. Med. 341: 452-453. PMid:10438269   Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, et al. (2006). Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur. Urol. 49: 466-477. PMid:16442208   Tran J, Rak J, Sheehan C, Saibil SD, et al. (1999). Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem. Biophys. Res. Commun. 264: 781-788. PMid:10544009   Waters WB (1996). Invasive bladder cancer - where do we go from here? J. Urol. 155: 1910-1911.   Zhu H, Chen XP, Zhang WG, Luo SF, et al. (2005). Expression and significance of new inhibitor of apoptosis protein survivin in hepatocellular carcinoma. World J. Gastroenterol. 11: 3855-3859. PMid:15991282
H. Song, Liu, Y., Pan, J., and Zhao, S. T., Expression profile analysis reveals putative prostate cancer-related microRNAs, vol. 12, pp. 4934-4943, 2013.